US › Healthcare

Celcuity LLC (CELC)

US · Healthcare · Biotechnology

$92.49+5.44%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$-52.8M
Profit YoY
-42.8%
EPS
$-0.86
EPS estimate
$-0.89

EPS came in at -0.86 against a street estimate of -0.89 — a beat of 3.4%.

Key statistics

Market cap
$4.21B
Forward P/E
0.0
P/B
78.70
Book value
$1.11
EPS (TTM)
$-3.90
52-week high
$151.02
52-week low
$42.28
50-day MA
$100.54
200-day MA
$103.72
Beta
0.20

Analyst view

Analysts rate Celcuity LLC a strong buy (7 buy, 0 hold, 0 sell out of 7) with an average price target of $163.54.

Shareholding

Insiders
10.03%
Institutions
95.77%

Largest institutional holders

FundStake
Baker Bros Advisors LP16.23%
venBio Select Advisor LLC6.92%
Perceptive Advisors LLC6.41%
RTW INVESTMENTS, LLC6.23%
BlackRock Inc5.56%
NEA Management Company, LLC4.69%
Vanguard Capital Management, LLC3.66%
Deerfield Management Co3.51%

Recent filings & reports

DocumentDate
Reg FD disclosure · Q3 20262026-07-15
Material agreement · Q2 20262026-06-08
Reg FD disclosure · Q2 20262026-06-02
Board / officer change · Q2 20262026-05-18
Quarterly report · Q1 20262026-05-14
Proxy statement · Q2 20262026-04-02
Annual report FY20252026-03-26
Quarterly report · Q3 20252025-11-13

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Celcuity LLC — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.